New Insights into Cancer Treatment Emerge
Recent studies have provided new insights into cancer treatment, potentially paving the way for more effective therapies.
Roche’s breast cancer entrant Itovebi bolsters clinical profile with overall survival win
Roches freshly approved PI3K inhibitor Itovebi can help extend the lives of certain patients with breast cancer when used in combination with two established medicines, new survival data from the drugs pivotal phase 3 trial show.
